Screener
Wave Life Sciences WVE Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 51,293 | 43,469 | 98,733 | 84,091 |
| General and administrative | 24,781 | 17,989 | 46,884 | 36,346 |
| Total operating expenses | 76,074 | 61,458 | 145,617 | 120,437 |
| Loss from operations | (73,802) | (52,759) | (105,099) | (102,563) |
| Other income, net: | ||||
| Interest income | 4,722 | 2,372 | 10,013 | 5,247 |
| Other expense | (275) | (82) | (356) | (31) |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's other operating expenses?
- Wave Life Sciences (WVE) reported other operating expenses of $76.07M in Q2 2026.
- How has Wave Life Sciences's other operating expenses changed year-over-year?
- Wave Life Sciences's other operating expenses increased by 23.8% year-over-year, from $61.46M to $76.07M.
- What is the long-term trend for Wave Life Sciences's other operating expenses?
- Over 4 years (2021 to 2025), Wave Life Sciences's other operating expenses has grown at a 11.3% compound annual growth rate (CAGR), from $167.98M to $258.11M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Wave Life Sciences's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude